Literature DB >> 34016839

The Impacts of COVID-19 on Veterans Affairs Catheterization Laboratory Staff During the First Months of the US Response.

Heather M Gilmartin1, Mary E Plomondon, Candice Mueller, Brigid Connelly, Catherine Battaglia, Stephen W Waldo, Jacob Doll.   

Abstract

BACKGROUND: The COVID-19 pandemic has altered catheterization laboratory (cath lab) practices in diverse ways.
OBJECTIVE: The aim of this study was to understand the impact of COVID-19 on Veterans Affairs (VA) procedural volume and cath lab team experience.
METHODS: Procedural volume and COVID-19 patient data were obtained from the Clinical, Assessment, Reporting and Tracking Program. A mixed methods survey was emailed to VA cath lab staff asking about the COVID-19 response. Descriptive and manifest content analyses were conducted.
RESULTS: Procedural volume decreased from April to September 2020. One hundred four patients with known COVID-19 were treated. Survey response rate was 19% of staff (n = 170/902) from 83% of VA cath labs (n = 67/81). Reassignment to other units, confusion regarding COVID-19 testing, personal protective equipment use, and low patient volume were reported. Anxiety, burnout, and leadership's role on team morale were described.
CONCLUSIONS: Some teams adapted. Others expressed frustration over the lack of control over their practice. Leaders should routinely assess staff needs during the current and future crises.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34016839     DOI: 10.1097/JCN.0000000000000828

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  1 in total

1.  Learning environments, reliability enhancing work practices, employee engagement, and safety climate in VA cardiac catheterization laboratories.

Authors:  Heather M Gilmartin; Edward Hess; Candice Mueller; Brigid Connelly; Mary E Plomondon; Stephen W Waldo; Catherine Battaglia
Journal:  Health Serv Res       Date:  2022-04       Impact factor: 3.734

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.